[1]JournaloftheAmericanChemicalSociety,2003,vol.125,p.7792-7793
[2]Synthesis,2011,p.857-859
[3]JournalofMedicinalChemistry,2017,vol.60,p.6451-6457
[4]Patent:WO2019/126759,2019,A1
13659-23-9
174913-20-3
855836-62-3
1940-42-7
13631-21-5
1940-44-9
112735-05-4 | 3-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-oxopropanenitrile | AA007SAX | MFCD01850800
111348-61-9 | L-Cysteine,N-acetyl-S-(1,2,2-trichloroethenyl)- | AA007T2R | MFCD02751655
111081-10-8 | tert-Butyl benzo[d][1,3]dioxol-4-ylcarbamate | AA007TQT | MFCD09038117
1744-07-6 | 1,3-Bis[4-(trifluoromethyl)phenyl]thiourea | AA007UEF | MFCD18191886
1082066-52-1 | 3-Fluoro-4-hydroxymethylbenzeneboronic acid | AA007V2R | MFCD13181609
1076-56-8 | Benzene,2-methoxy-4-methyl-1-(1-methylethyl)- | AA007VR8 | MFCD19441453
105454-04-4 | 7-Epitaxol | AA007WC4 | MFCD07783713
16256-47-6 | 2-(Isopropylamino)-2-methylpropanenitrile | AA007WRW | MFCD06357358
154634-94-3 | (3S,5S)-3,5-Dimethylmorpholine hydrochloride | AA007XDE | MFCD16036180
153719-23-4 | N-(3-((2-Chlorothiazol-5-yl)methyl)-5-methyl-1,3,5-oxadiazinan-4-ylidene)nitramide | AA007XV5 | MFCD03792862